NICOTINE ENHANCES 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE NEUROTOXICITY

被引:49
|
作者
BEHMAND, RA
HARIK, SI
机构
[1] UNIV HOSP CLEVELAND,DEPT NEUROL,2074 ABINGTON RD,CLEVELAND,OH 44106
[2] CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
关键词
CIGARETTE SMOKING; NICOTINE; PARKINSONS DISEASE; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE NEUROTOXICITY; NIGROSTRIATAL DOPAMINERGIC SYSTEM; NIGROSTRIATAL DEGENERATION;
D O I
10.1111/j.1471-4159.1992.tb09786.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epidemiologic evidence of an inverse relationship between cigarette smoking and Parkinson's disease suggests that a component of cigarette smoke protects against nigrostriatal degeneration. Nicotine, a major component of cigarette smoke, is similar in chemical structure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and is metabolized in part by the same enzymes that detoxify MPTP. We investigated the effect of chronic nicotine on MPTP neurotoxicity in two strains of mice and found that nicotine increases rather than decreases MPTP toxicity. These results are not compatible with the hypothesis that nicotine is that component of cigarette smoke that protects against nigrostriatal degeneration, at least in the MPTP experimental model of Parkinson's disease.
引用
收藏
页码:776 / 779
页数:4
相关论文
共 50 条
  • [1] Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
    Hare, Dominic J.
    Adlard, Paul A.
    Doble, Philip A.
    Finkelstein, David I.
    METALLOMICS, 2013, 5 (02) : 91 - 109
  • [2] THE NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE IN THE MONKEY AND MAN
    BURNS, RS
    MARKEY, SP
    PHILLIPS, JM
    CHIUEH, CC
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) : 166 - 168
  • [3] ON THE MECHANISMS UNDERLYING 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) NEUROTOXICITY
    HARIK, SI
    IACOFANO, LA
    SAYRE, LM
    ARORA, PK
    BLUE, P
    SCHMIDLEY, JW
    NEUROLOGY, 1986, 36 (04) : 288 - 289
  • [4] Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
    Cleren, C
    Starkov, AA
    Calingasan, NY
    Lorenzo, BJ
    Chen, JY
    Beal, MF
    NEUROBIOLOGY OF DISEASE, 2005, 20 (03) : 701 - 708
  • [5] ON THE MECHANISMS UNDERLYING 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE NEUROTOXICITY - THE EFFECT OF PERINIGRAL INFUSION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE, ITS METABOLITE AND THEIR ANALOGS IN THE RAT
    HARIK, SI
    SCHMIDLEY, JW
    IACOFANO, LA
    BLUE, P
    ARORA, PK
    SAYRE, LM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 241 (02): : 669 - 676
  • [6] THE SIGNIFICANCE OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE
    MARSDEN, CD
    JENNER, PG
    CIBA FOUNDATION SYMPOSIA, 1987, 126 : 239 - 256
  • [7] ROLE OF REACTIVE OXYGEN SPECIES IN 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE NEUROTOXICITY
    LAI, M
    GRIFFITHS, HR
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (03) : 416 - 417
  • [8] Mutagenic activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    Ulanowska, K
    Wegrzyn, G
    JOURNAL OF APPLIED GENETICS, 2006, 47 (01) : 85 - 87
  • [9] DITHIOCARBAMATES ENHANCE NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE AND ITS ANALOGS
    BACHURIN, SO
    LERMONTOVA, NN
    SERKOVA, TP
    DOKLADY AKADEMII NAUK, 1993, 328 (03) : 399 - 402
  • [10] EFFECT OF AMPHETAMINE ON 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) NEUROTOXICITY IN MICE
    SERSHEN, H
    MASON, MF
    REITH, MEA
    HASHIM, A
    LAJTHA, A
    NEUROPHARMACOLOGY, 1986, 25 (08) : 927 - 930